Viewing Study NCT01908192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2026-02-19 @ 8:00 PM
Study NCT ID: NCT01908192
Status: TERMINATED
Last Update Posted: 2024-05-09
First Post: 2013-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
Sponsor: SyneuRx International (Taiwan) Corp
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sodium Benzoate View
None Schizophrenia View
None Adolescent View
None Antipsychotic View
None Anti-psychotic View
None NMDA View
None NaBen View
None pediatric View